Home Patent dispute settlement to benefit Penn cancer therapy partnership
 

Keywords :   


Patent dispute settlement to benefit Penn cancer therapy partnership

2015-04-08 13:56:58| Biotech - Topix.net

Novartis Pharmaceutical Corp. settled its patent dispute with Juno Therapeutics, removing any potential litigation obstacles from the immunotherapy partnership between Novartis and the University of Pennsylvania. The Wall Street Journal reported Novartis will pay Seattle-based Juno $12.25 million, plus undisclosed future milestone payments and royalties, to resolve the dispute.

Tags: benefit partnership cancer therapy

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
04.10Summary for Hurricane Kirk (AT2/AL122024)
04.10Tropical Storm Leslie Public Advisory Number 10
More »